Authors: Miller, V Vandamme, AM Loveday, C Staszewski, S Lundgren, J Youle, M Ait-Khaled, M Boucher, C Brun-Vezinet, F Dedes, N Giaquinto, C Hertogs, K Houyez, F Perrin, L Pillay, D Schmit, JC Schuurman, R Lange, J Banhegyi, D Biondi, G Broekhuizen, A Bush-Donovan, C Camacho, R Carlier, H Clavel, F Clotet, B Clumeck, N Colebunders, R De Clerq, K De Jaegher, JJ De Schrijver, G De Smet, K Hall, W Harrigan, R Hatzakis, A Hellmann, N Hoetelmans, R Holtzer, C Katlama, C Larder, D Loriaux, E McCreedy, B Mulcahy, F Opravil, M Phillips, A Ruiz, N Shulse, E Sonnerborg, A Soriano, V Steel, H Vella, S Williams, A

Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320

Authors: Loeliger, AE Steel, H McGuirk, S Powell, WS Hetherington, SV

Citation: Ae. Loeliger et al., The abacavir hypersensitivity reaction and interruptions in therapy, AIDS, 15(10), 2001, pp. 1325-1325

Authors: Hetherington, S McGuirk, S Powell, G Cutrell, A Naderer, O Spreen, B Lafon, S Pearce, G Steel, H

Citation: S. Hetherington et al., Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir, CLIN THER, 23(10), 2001, pp. 1603-1614

Authors: Staszewski, S Keiser, P Montaner, J Raffi, F Gathe, J Brotas, V Hicks, C Hammer, SM Cooper, D Johnson, M Tortell, S Cutrell, A Thorborn, D Isaacs, R Hetherington, S Steel, H Spreen, W

Citation: S. Staszewski et al., Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial, J AM MED A, 285(9), 2001, pp. 1155-1163